Ensol Biosciences Inc. (XKON: 140610)
South Korea
· Delayed Price · Currency is KRW
6,220.00
-240.00 (-3.72%)
Sep 10, 2024, 9:00 AM KST
Ensol Biosciences Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2017 | FY 2016 | FY 2015 |
| Sep '24 Sep 9, 2024 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
| Debt / Equity Ratio | 0.00 | 0.00 | - | 0.18 |
| Debt / FCF Ratio | -0.01 | -0.01 | - | -0.73 |
| Asset Turnover | 0.05 | 0.05 | 0.01 | - |
| Quick Ratio | 8.46 | 8.46 | 12.53 | 3.74 |
| Current Ratio | 9.01 | 9.01 | 12.84 | 3.79 |
| Return on Equity (ROE) | -59.14% | -59.14% | -54.70% | - |
| Return on Assets (ROA) | -31.45% | -31.45% | -22.54% | - |
| Return on Capital (ROIC) | -35.28% | -35.28% | -24.35% | - |
| Buyback Yield / Dilution | -1.79% | -22.68% | - |
| Total Shareholder Return | -1.79% | -22.68% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.